As of Jul 06
| +1.46 / +3.15%|
The 10 analysts offering 12-month price forecasts for Impax Laboratories Inc have a median target of 49.50, with a high estimate of 58.00 and a low estimate of 36.00. The median estimate represents a +3.62% increase from the last price of 47.77.
The current consensus among 11 polled investment analysts is to Hold stock in Impax Laboratories Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.